Piketon Facility Expansion
In a major milestone for domestic uranium enrichment, Centrus Energy reported a $900 million task order from the U.S. Department of Energy (DOE) in January 2026. This significant investment is dedicated to expanding the company's Piketon, Ohio facility to support commercial-scale High-Assay Low-Enriched Uranium (HALEU) production. The expansion project involves strategic collaboration with Fluor, a leading global engineering and construction firm, to ensure the facility meets rigorous commercial standards.
Production Timeline and Capabilities
The modernization and expansion of the Piketon site are critical for bridging the current HALEU supply gap. HALEU deliveries from the expanded Piketon facility are anticipated to commence in 2029. This timeline aligns perfectly with the fueling requirements of next-generation advanced reactors currently in the licensing and deployment phases across the United States.
AC100 Centrifuge Technology
Central to Centrus' enrichment strategy is the AC100 centrifuge design, which stands as the only deployment-ready U.S.-origin technology currently available for unobligated enrichment. This technology relies on a robust U.S. manufacturing supply chain, ensuring that the enriched uranium can be utilized for sensitive national security applications without geopolitical constraints. By combining the AC100 technology with the expanded Piketon infrastructure, Centrus is solidifying its position as the cornerstone of the revived U.S. enrichment supply chain.
The AC100 centrifuge design is currently the only deployment-ready U.S.-origin technology available for unobligated enrichment.
This article was assisted by AI analysis. Please refer to the original source for official information.